From: Who are the key players in a new translational research network?
Variable | Survey items |
---|---|
Altruistic approach | Deeply committed to the TRN’s objectives, offering expertise, representing other workgroups, disseminating findings |
Active role | Attended formal meetings of the TRN, initiated meetings, involved in a TRN project, provided advice for TRN projects |
Resources (Cronbach’s alpha: 0.76) | Enabler: Adequate funding, access to shared resources and expertise, support of Project Officers and Fellows Barriers: Lack of adequate funding |
No Incentives (Cronbach’s alpha: 0.78) | Barriers: Lack of incentives, lack of time, lack of interest from colleagues, difficulties of collaborations |
Focus (Cronbach’s alpha: 0.73) | Enablers: Projects focused on patient outcomes, strong leadership, good communication, social capital of members Barriers: Poor or absent links between researchers and clinicians |